naturalX Health Ventures
Venture investment vehicle backed by Schwabe Group
Also known as naturalX, naturalX.vc
Karlsruhe consumer-health venture vehicle with a €100m commitment from the Schwabe Group; leads Series A/B rounds with €3–5m tickets (up to €10m) and also invests in funds as an LP.
Karlsruhe consumer-health venture vehicle backed by the Schwabe Group; not NaturalX or other similarly named natural-products companies.
- HEADQUARTERS
- Karlsruhe, Germany
- FOUNDED
- —
- AUM
- €100M (2026)
- OUTSIDE CAPITAL
- No — own capital only
- TEAM LISTED
- 5 people
FOCUS
- STAGES
- SeedSeries ASeries B
- ASSET MIX
- Venture capitalFunds (as LP)
- GEOGRAPHY
- Europe
WHAT IT IS
Corporate VC. A corporation investing from its own balance sheet, usually with strategic goals.
ABOUT
naturalX Health Ventures invests in consumer health companies at the intersection of wellness and medicine, with a focus on proactive health (prevention, longevity, sleep, nutrition, diagnostics, wearables, digital therapeutics) and mental health. It is backed by the Schwabe Group, a maker of plant-based pharmaceuticals, works with a €100m capital commitment and is not bound to fund cycles; its investment committee is led by the CEO of Schwabe Group. It prefers Series A, can lead rounds with typical tickets of €3–5m and reserves up to €10m per company, and also makes fund investments as an LP. Holdings include Function Health, Hilo (formerly Aktiia), Flow Neuroscience and Jutro Medical.
INVESTMENT THESIS
Consumer health with scientifically backed products and strong customer or patient engagement: proactive health (prevention and longevity, sleep, nutrition and supplements, biohacking, genomics, wearables, digital therapeutics, at-home diagnostics, remote care) and digital or alternative mental-health solutions; flexible from seed to late stage but focused on Series A and B with product-market fit.
PORTFOLIO (8)
- Function HealthNOTABLEHealthTech
- Hilo (formerly Aktiia)NOTABLEHealthTech
- HealthTech · since 2026
- HealthTech
- HealthTech
- HealthTech
- HealthTech
- Consumer & E-commerce
TEAM
LINKS
FAQ
naturalX Health Ventures is a corporate venture arm based in Karlsruhe, Germany.
Yes. naturalX Health Ventures invests directly in private companies. It also commits capital to third-party funds as an LP.
naturalX Health Ventures invests at Seed, Series A and Series B stages in HealthTech and Consumer & E-commerce.
naturalX Health Ventures's stated ticket size is €3M–€5M.
Key people at naturalX Health Ventures include Marvin Amberg (Managing Director), Oliver Schulz (Managing Director (per Impressum)), Clementine Provost (Investor) and Yang Chen, PhD (Investor).
naturalX Health Ventures's investments include Function Health, Hilo (formerly Aktiia), Ilant Health, Jutro Medical, Kyan Health, Flow Neuroscience, Meela Health and mybacs.
The most recent publicly reported investment by naturalX Health Ventures is Ilant Health (Series A ($15m, led by Cornucopian Capital; naturalX participated)), announced in Jun 2026.
No. naturalX Health Ventures invests its own capital and does not raise money from outside investors.